Cargando…

Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence

BACKGROUND: Several clinical studies have indicated that selective serotonin reuptake inhibitors (SSRIs) administered in patients after acute ischemic stroke can improve clinical recovery independently of depression. Due to small sample sizes and heterogeneous study designs interpretability was limi...

Descripción completa

Detalles Bibliográficos
Autores principales: Siepmann, Timo, Penzlin, Ana Isabel, Kepplinger, Jessica, Illigens, Ben Min‐Woo, Weidner, Kerstin, Reichmann, Heinz, Barlinn, Kristian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614057/
https://www.ncbi.nlm.nih.gov/pubmed/26516608
http://dx.doi.org/10.1002/brb3.373
_version_ 1782396353891008512
author Siepmann, Timo
Penzlin, Ana Isabel
Kepplinger, Jessica
Illigens, Ben Min‐Woo
Weidner, Kerstin
Reichmann, Heinz
Barlinn, Kristian
author_facet Siepmann, Timo
Penzlin, Ana Isabel
Kepplinger, Jessica
Illigens, Ben Min‐Woo
Weidner, Kerstin
Reichmann, Heinz
Barlinn, Kristian
author_sort Siepmann, Timo
collection PubMed
description BACKGROUND: Several clinical studies have indicated that selective serotonin reuptake inhibitors (SSRIs) administered in patients after acute ischemic stroke can improve clinical recovery independently of depression. Due to small sample sizes and heterogeneous study designs interpretability was limited in these studies. The mechanisms of action whereby SSRI might improve recovery from acute ischemic stroke are not fully elucidated. METHODS: We searched MEDLINE using the PubMed interface to identify evidence of SSRI mediated improvement of recovery from acute ischemic stroke and reviewed the literature on the potential underlying mechanisms of action. RESULTS: Among identified clinical studies, a well‐designed randomized, double‐blind, and placebo‐controlled study (FLAME ‐ fluoxetine for motor recovery after acute ischemic stroke) demonstrated improved recovery of motor function in stroke patients receiving fluoxetine. The positive effects of SSRIs on stroke recovery were further supported by a meta‐analysis of 52 trials in a total of 4060 participants published by the Cochrane collaboration. Based on animal models, the mechanisms whereby SSRIs might ameliorate functional and structural ischemic‐brain damage were suggested to include stimulation of neurogenesis with migration of newly generated cells toward ischemic‐brain regions, anti‐inflammatory neuroprotection, improved regulation of cerebral blood flow, and modulation of the adrenergic neurohormonal system. However, to date, it remains speculative if and to what degree these mechanisms convert into humans and randomized controlled trials in large populations of stroke patients comparing different SSRIs are still lacking. CONCLUSION: In addition to the need of comprehensive‐clinical evidence, further elucidation of the beneficial mechanisms whereby SSRIs may improve structural and functional recovery from ischemic‐brain damage is needed to form a basis for translation into clinical practice.
format Online
Article
Text
id pubmed-4614057
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-46140572015-10-29 Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence Siepmann, Timo Penzlin, Ana Isabel Kepplinger, Jessica Illigens, Ben Min‐Woo Weidner, Kerstin Reichmann, Heinz Barlinn, Kristian Brain Behav Reviews BACKGROUND: Several clinical studies have indicated that selective serotonin reuptake inhibitors (SSRIs) administered in patients after acute ischemic stroke can improve clinical recovery independently of depression. Due to small sample sizes and heterogeneous study designs interpretability was limited in these studies. The mechanisms of action whereby SSRI might improve recovery from acute ischemic stroke are not fully elucidated. METHODS: We searched MEDLINE using the PubMed interface to identify evidence of SSRI mediated improvement of recovery from acute ischemic stroke and reviewed the literature on the potential underlying mechanisms of action. RESULTS: Among identified clinical studies, a well‐designed randomized, double‐blind, and placebo‐controlled study (FLAME ‐ fluoxetine for motor recovery after acute ischemic stroke) demonstrated improved recovery of motor function in stroke patients receiving fluoxetine. The positive effects of SSRIs on stroke recovery were further supported by a meta‐analysis of 52 trials in a total of 4060 participants published by the Cochrane collaboration. Based on animal models, the mechanisms whereby SSRIs might ameliorate functional and structural ischemic‐brain damage were suggested to include stimulation of neurogenesis with migration of newly generated cells toward ischemic‐brain regions, anti‐inflammatory neuroprotection, improved regulation of cerebral blood flow, and modulation of the adrenergic neurohormonal system. However, to date, it remains speculative if and to what degree these mechanisms convert into humans and randomized controlled trials in large populations of stroke patients comparing different SSRIs are still lacking. CONCLUSION: In addition to the need of comprehensive‐clinical evidence, further elucidation of the beneficial mechanisms whereby SSRIs may improve structural and functional recovery from ischemic‐brain damage is needed to form a basis for translation into clinical practice. John Wiley and Sons Inc. 2015-09-23 /pmc/articles/PMC4614057/ /pubmed/26516608 http://dx.doi.org/10.1002/brb3.373 Text en © 2015 The Authors. Brain and Behavior published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Siepmann, Timo
Penzlin, Ana Isabel
Kepplinger, Jessica
Illigens, Ben Min‐Woo
Weidner, Kerstin
Reichmann, Heinz
Barlinn, Kristian
Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence
title Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence
title_full Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence
title_fullStr Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence
title_full_unstemmed Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence
title_short Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence
title_sort selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614057/
https://www.ncbi.nlm.nih.gov/pubmed/26516608
http://dx.doi.org/10.1002/brb3.373
work_keys_str_mv AT siepmanntimo selectiveserotoninreuptakeinhibitorstoimproveoutcomeinacuteischemicstrokepossiblemechanismsandclinicalevidence
AT penzlinanaisabel selectiveserotoninreuptakeinhibitorstoimproveoutcomeinacuteischemicstrokepossiblemechanismsandclinicalevidence
AT kepplingerjessica selectiveserotoninreuptakeinhibitorstoimproveoutcomeinacuteischemicstrokepossiblemechanismsandclinicalevidence
AT illigensbenminwoo selectiveserotoninreuptakeinhibitorstoimproveoutcomeinacuteischemicstrokepossiblemechanismsandclinicalevidence
AT weidnerkerstin selectiveserotoninreuptakeinhibitorstoimproveoutcomeinacuteischemicstrokepossiblemechanismsandclinicalevidence
AT reichmannheinz selectiveserotoninreuptakeinhibitorstoimproveoutcomeinacuteischemicstrokepossiblemechanismsandclinicalevidence
AT barlinnkristian selectiveserotoninreuptakeinhibitorstoimproveoutcomeinacuteischemicstrokepossiblemechanismsandclinicalevidence